497 related articles for article (PubMed ID: 37666809)
1. Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications.
Fang J; Lu Y; Zheng J; Jiang X; Shen H; Shang X; Lu Y; Fu P
Cell Death Dis; 2023 Sep; 14(9):586. PubMed ID: 37666809
[TBL] [Abstract][Full Text] [Related]
2. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
[TBL] [Abstract][Full Text] [Related]
3. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cells in tumor microenvironment: insights and perspectives.
Leone P; Malerba E; Susca N; Favoino E; Perosa F; Brunori G; Prete M; Racanelli V
Front Immunol; 2024; 15():1367875. PubMed ID: 38426109
[TBL] [Abstract][Full Text] [Related]
5. From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review.
Regmi M; Wang Y; Liu W; Dai Y; Liu S; Ma K; Lin G; Yang J; Liu H; Wu J; Yang C
J Exp Clin Cancer Res; 2024 Feb; 43(1):47. PubMed ID: 38342925
[TBL] [Abstract][Full Text] [Related]
6. Paracrine Regulation and Immune System Pathways in the Inflammatory Tumor Microenvironment of Lung Cancer: Insights into Oncogenesis and Immunotherapeutic Strategies.
Batrash F; Shaik A; Rauf R; Kutmah M; Zhang J
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539448
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches.
Iozzo M; Sgrignani G; Comito G; Chiarugi P; Giannoni E
Cells; 2021 Dec; 10(12):. PubMed ID: 34943903
[TBL] [Abstract][Full Text] [Related]
8. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
[TBL] [Abstract][Full Text] [Related]
9. Emerging immune checkpoints in the tumor microenvironment: Implications for cancer immunotherapy.
Wei G; Zhang H; Zhao H; Wang J; Wu N; Li L; Wu J; Zhang D
Cancer Lett; 2021 Jul; 511():68-76. PubMed ID: 33957184
[TBL] [Abstract][Full Text] [Related]
10. Wnt Signaling in the Tumor Microenvironment.
Ruan Y; Ogana H; Gang E; Kim HN; Kim YM
Adv Exp Med Biol; 2021; 1270():107-121. PubMed ID: 33123996
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory properties of the lymphatic endothelium in the tumor microenvironment.
Viúdez-Pareja C; Kreft E; García-Caballero M
Front Immunol; 2023; 14():1235812. PubMed ID: 37744339
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies.
Peng X; Zheng J; Liu T; Zhou Z; Song C; Geng Y; Wang Z; Huang Y
Curr Cancer Drug Targets; 2024; 24(3):288-307. PubMed ID: 37537777
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies.
El-Tanani M; Rabbani SA; Babiker R; Rangraze I; Kapre S; Palakurthi SS; Alnuqaydan AM; Aljabali AA; Rizzo M; El-Tanani Y; Tambuwala MM
Cancer Lett; 2024 Jun; 591():216894. PubMed ID: 38626856
[TBL] [Abstract][Full Text] [Related]
15. Understanding the regulation of "Don't Eat-Me" signals by inflammatory signaling pathways in the tumor microenvironment for more effective therapy.
Karizak AZ; Salmasi Z; Gheibihayat SM; Asadi M; Ghasemi Y; Tajbakhsh A; Savardashtaki A
J Cancer Res Clin Oncol; 2023 Jan; 149(1):511-529. PubMed ID: 36342520
[TBL] [Abstract][Full Text] [Related]
16. Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment - New Findings and Future Perspectives.
Nagl L; Horvath L; Pircher A; Wolf D
Front Cell Dev Biol; 2020; 8():766. PubMed ID: 32974337
[TBL] [Abstract][Full Text] [Related]
17. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
Phuengkham H; Ren L; Shin IW; Lim YT
Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696
[TBL] [Abstract][Full Text] [Related]
18. Understanding the tumor microenvironment for effective immunotherapy.
Sadeghi Rad H; Monkman J; Warkiani ME; Ladwa R; O'Byrne K; Rezaei N; Kulasinghe A
Med Res Rev; 2021 May; 41(3):1474-1498. PubMed ID: 33277742
[TBL] [Abstract][Full Text] [Related]
19. CAF-immune cell crosstalk and its impact in immunotherapy.
Maia A; Schöllhorn A; Schuhmacher J; Gouttefangeas C
Semin Immunopathol; 2023 Mar; 45(2):203-214. PubMed ID: 36480035
[TBL] [Abstract][Full Text] [Related]
20. The Tumor Microenvironment Reprograms Immune Cells.
Cao H; Gao S; Jogani R; Sugimura R
Cell Reprogram; 2022 Dec; 24(6):343-352. PubMed ID: 36301256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
